Strategic leadership changes -- Eran Ophir became CEO in September 2025, with Anat Cohen-Dayag transitioning to Executive Chair to enhance operational focus and strategic continuity.

Shares of uniQure plummeted more than 40% in premarket trading Monday after the company confirmed the FDA has rejected its current data package for AMT-130, a highly anticipated gene therapy for ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

VANCOUVER, BC / ACCESS Newswire / March 2, 2026 / Revolve Renewable Power Corp. (CSE:REVV)(OTCQB:REVVF) ("Revolve" or ...

Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company focused on neuroinflammation and central nervous system disorders, today announced that management will participate ...

Maria Regina campus developers look to build new structure after converting existing buildings into affordable housing.

A new seven-story luxury hotel could rise next to a Sunrise shopping center just west of I-75, a plan that has drawn mixed reactions.

Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.

That committee will now review the four Phase 2 proposals and present a ranked list to the City Commission, which will cast the final vote on a developer. Residents can weigh in on the proposals here ...

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...